nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—Cerebral ischaemia—Ramipril—type 1 diabetes mellitus	0.0242	0.0318	CcSEcCtD
Sibutramine—Peripheral vascular disorder—Ramipril—type 1 diabetes mellitus	0.0238	0.0313	CcSEcCtD
Sibutramine—Transient ischaemic attack—Ramipril—type 1 diabetes mellitus	0.0232	0.0304	CcSEcCtD
Sibutramine—SLC6A3—Alpha-synuclein signaling—TOR1A—type 1 diabetes mellitus	0.0218	0.0916	CbGpPWpGaD
Sibutramine—SLC6A4—Serotonin Transporter Activity—IL1R1—type 1 diabetes mellitus	0.0217	0.0908	CbGpPWpGaD
Sibutramine—Psoriasis—Ramipril—type 1 diabetes mellitus	0.0186	0.0244	CcSEcCtD
Sibutramine—Parosmia—Ramipril—type 1 diabetes mellitus	0.018	0.0237	CcSEcCtD
Sibutramine—Neuralgia—Ramipril—type 1 diabetes mellitus	0.0168	0.0221	CcSEcCtD
Sibutramine—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.0135	0.0177	CcSEcCtD
Sibutramine—SLC6A4—Serotonin Transporter Activity—NOS1—type 1 diabetes mellitus	0.0131	0.055	CbGpPWpGaD
Sibutramine—Cough increased—Ramipril—type 1 diabetes mellitus	0.0128	0.0168	CcSEcCtD
Sibutramine—Glossitis—Ramipril—type 1 diabetes mellitus	0.0127	0.0167	CcSEcCtD
Sibutramine—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.0124	0.0163	CcSEcCtD
Sibutramine—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.0123	0.0161	CcSEcCtD
Sibutramine—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.0114	0.0149	CcSEcCtD
Sibutramine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC18A2—type 1 diabetes mellitus	0.0111	0.0466	CbGpPWpGaD
Sibutramine—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.011	0.0145	CcSEcCtD
Sibutramine—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC18A2—type 1 diabetes mellitus	0.00984	0.0413	CbGpPWpGaD
Sibutramine—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.0098	0.0129	CcSEcCtD
Sibutramine—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00966	0.0127	CcSEcCtD
Sibutramine—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00957	0.0126	CcSEcCtD
Sibutramine—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00948	0.0125	CcSEcCtD
Sibutramine—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00931	0.0122	CcSEcCtD
Sibutramine—SLC6A4—Monoamine Transport—IL1R1—type 1 diabetes mellitus	0.00921	0.0387	CbGpPWpGaD
Sibutramine—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00915	0.012	CcSEcCtD
Sibutramine—Amnesia—Ramipril—type 1 diabetes mellitus	0.00903	0.0119	CcSEcCtD
Sibutramine—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00895	0.0118	CcSEcCtD
Sibutramine—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00892	0.0117	CcSEcCtD
Sibutramine—Purpura—Ramipril—type 1 diabetes mellitus	0.0088	0.0116	CcSEcCtD
Sibutramine—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.00877	0.0115	CcSEcCtD
Sibutramine—Arthritis—Ramipril—type 1 diabetes mellitus	0.00873	0.0115	CcSEcCtD
Sibutramine—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00869	0.0114	CcSEcCtD
Sibutramine—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00866	0.0114	CcSEcCtD
Sibutramine—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00842	0.0111	CcSEcCtD
Sibutramine—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00795	0.0104	CcSEcCtD
Sibutramine—SLC6A2—Monoamine Transport—IL1R1—type 1 diabetes mellitus	0.00792	0.0332	CbGpPWpGaD
Sibutramine—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00783	0.0103	CcSEcCtD
Sibutramine—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00775	0.0102	CcSEcCtD
Sibutramine—SLC6A2—Amine compound SLC transporters—SLC18A2—type 1 diabetes mellitus	0.00771	0.0323	CbGpPWpGaD
Sibutramine—Gastritis—Ramipril—type 1 diabetes mellitus	0.00751	0.00986	CcSEcCtD
Sibutramine—Influenza—Ramipril—type 1 diabetes mellitus	0.00733	0.00963	CcSEcCtD
Sibutramine—Asthma—Ramipril—type 1 diabetes mellitus	0.00733	0.00963	CcSEcCtD
Sibutramine—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00733	0.00963	CcSEcCtD
Sibutramine—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00726	0.00953	CcSEcCtD
Sibutramine—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00714	0.00938	CcSEcCtD
Sibutramine—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00705	0.00926	CcSEcCtD
Sibutramine—SLC6A3—Monoamine Transport—IL1R1—type 1 diabetes mellitus	0.00702	0.0295	CbGpPWpGaD
Sibutramine—SLC6A3—Amine compound SLC transporters—SLC18A2—type 1 diabetes mellitus	0.00683	0.0287	CbGpPWpGaD
Sibutramine—SLC6A3—Dopaminergic Neurogenesis—SLC18A2—type 1 diabetes mellitus	0.00683	0.0287	CbGpPWpGaD
Sibutramine—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00675	0.00887	CcSEcCtD
Sibutramine—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00669	0.00879	CcSEcCtD
Sibutramine—Weight increased—Ramipril—type 1 diabetes mellitus	0.00667	0.00876	CcSEcCtD
Sibutramine—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00645	0.00846	CcSEcCtD
Sibutramine—Renal failure—Ramipril—type 1 diabetes mellitus	0.00643	0.00844	CcSEcCtD
Sibutramine—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00641	0.00841	CcSEcCtD
Sibutramine—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00641	0.00841	CcSEcCtD
Sibutramine—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00637	0.00837	CcSEcCtD
Sibutramine—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00636	0.00834	CcSEcCtD
Sibutramine—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00636	0.00834	CcSEcCtD
Sibutramine—Sweating—Ramipril—type 1 diabetes mellitus	0.00627	0.00823	CcSEcCtD
Sibutramine—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00617	0.0081	CcSEcCtD
Sibutramine—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00613	0.00805	CcSEcCtD
Sibutramine—SLC6A4—Synaptic Vesicle Pathway—SLC18A2—type 1 diabetes mellitus	0.00586	0.0246	CbGpPWpGaD
Sibutramine—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00578	0.00759	CcSEcCtD
Sibutramine—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00566	0.00743	CcSEcCtD
Sibutramine—SLC6A4—Monoamine Transport—NOS1—type 1 diabetes mellitus	0.00558	0.0234	CbGpPWpGaD
Sibutramine—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00547	0.00719	CcSEcCtD
Sibutramine—SLC6A4—Serotonin Transporter Activity—IL1B—type 1 diabetes mellitus	0.00535	0.0225	CbGpPWpGaD
Sibutramine—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.0053	0.00696	CcSEcCtD
Sibutramine—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00524	0.00688	CcSEcCtD
Sibutramine—Alopecia—Ramipril—type 1 diabetes mellitus	0.00519	0.00681	CcSEcCtD
Sibutramine—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00511	0.00671	CcSEcCtD
Sibutramine—Tension—Ramipril—type 1 diabetes mellitus	0.00501	0.00658	CcSEcCtD
Sibutramine—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.005	0.00657	CcSEcCtD
Sibutramine—Nervousness—Ramipril—type 1 diabetes mellitus	0.00496	0.00652	CcSEcCtD
Sibutramine—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00491	0.00645	CcSEcCtD
Sibutramine—SLC6A2—Monoamine Transport—NOS1—type 1 diabetes mellitus	0.0048	0.0201	CbGpPWpGaD
Sibutramine—Tremor—Ramipril—type 1 diabetes mellitus	0.00479	0.00629	CcSEcCtD
Sibutramine—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00474	0.00622	CcSEcCtD
Sibutramine—Agitation—Ramipril—type 1 diabetes mellitus	0.0047	0.00616	CcSEcCtD
Sibutramine—Angioedema—Ramipril—type 1 diabetes mellitus	0.00467	0.00613	CcSEcCtD
Sibutramine—Malaise—Ramipril—type 1 diabetes mellitus	0.00461	0.00605	CcSEcCtD
Sibutramine—Vertigo—Ramipril—type 1 diabetes mellitus	0.00459	0.00603	CcSEcCtD
Sibutramine—Syncope—Ramipril—type 1 diabetes mellitus	0.00458	0.00602	CcSEcCtD
Sibutramine—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00457	0.006	CcSEcCtD
Sibutramine—Palpitations—Ramipril—type 1 diabetes mellitus	0.00452	0.00593	CcSEcCtD
Sibutramine—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00449	0.0059	CcSEcCtD
Sibutramine—Cough—Ramipril—type 1 diabetes mellitus	0.00446	0.00585	CcSEcCtD
Sibutramine—Convulsion—Ramipril—type 1 diabetes mellitus	0.00443	0.00581	CcSEcCtD
Sibutramine—Myalgia—Ramipril—type 1 diabetes mellitus	0.00435	0.00571	CcSEcCtD
Sibutramine—Chest pain—Ramipril—type 1 diabetes mellitus	0.00435	0.00571	CcSEcCtD
Sibutramine—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00435	0.00571	CcSEcCtD
Sibutramine—Anxiety—Ramipril—type 1 diabetes mellitus	0.00434	0.00569	CcSEcCtD
Sibutramine—Discomfort—Ramipril—type 1 diabetes mellitus	0.0043	0.00564	CcSEcCtD
Sibutramine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00425	0.00559	CcSEcCtD
Sibutramine—SLC6A3—Monoamine Transport—NOS1—type 1 diabetes mellitus	0.00425	0.0178	CbGpPWpGaD
Sibutramine—Confusional state—Ramipril—type 1 diabetes mellitus	0.0042	0.00552	CcSEcCtD
Sibutramine—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00417	0.00547	CcSEcCtD
Sibutramine—Oedema—Ramipril—type 1 diabetes mellitus	0.00417	0.00547	CcSEcCtD
Sibutramine—Shock—Ramipril—type 1 diabetes mellitus	0.0041	0.00539	CcSEcCtD
Sibutramine—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00408	0.00536	CcSEcCtD
Sibutramine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00407	0.00534	CcSEcCtD
Sibutramine—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00405	0.00532	CcSEcCtD
Sibutramine—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00403	0.00529	CcSEcCtD
Sibutramine—Anorexia—Ramipril—type 1 diabetes mellitus	0.00398	0.00522	CcSEcCtD
Sibutramine—Hypotension—Ramipril—type 1 diabetes mellitus	0.0039	0.00512	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.0038	0.00499	CcSEcCtD
Sibutramine—Insomnia—Ramipril—type 1 diabetes mellitus	0.00377	0.00495	CcSEcCtD
Sibutramine—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00374	0.00492	CcSEcCtD
Sibutramine—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00372	0.00488	CcSEcCtD
Sibutramine—Somnolence—Ramipril—type 1 diabetes mellitus	0.00371	0.00487	CcSEcCtD
Sibutramine—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00367	0.00482	CcSEcCtD
Sibutramine—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00363	0.00476	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.0036	0.00473	CcSEcCtD
Sibutramine—Constipation—Ramipril—type 1 diabetes mellitus	0.00357	0.00468	CcSEcCtD
Sibutramine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00344	0.00451	CcSEcCtD
Sibutramine—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00341	0.00448	CcSEcCtD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC29A3—type 1 diabetes mellitus	0.00341	0.0143	CbGpPWpGaD
Sibutramine—Urticaria—Ramipril—type 1 diabetes mellitus	0.00331	0.00435	CcSEcCtD
Sibutramine—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.0033	0.00433	CcSEcCtD
Sibutramine—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.0033	0.00433	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—PAX4—type 1 diabetes mellitus	0.00314	0.0132	CbGpPWpGaD
Sibutramine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00307	0.00403	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC29A3—type 1 diabetes mellitus	0.00302	0.0127	CbGpPWpGaD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—type 1 diabetes mellitus	0.00301	0.0126	CbGpPWpGaD
Sibutramine—Asthenia—Ramipril—type 1 diabetes mellitus	0.00299	0.00393	CcSEcCtD
Sibutramine—Pruritus—Ramipril—type 1 diabetes mellitus	0.00295	0.00387	CcSEcCtD
Sibutramine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00285	0.00375	CcSEcCtD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—type 1 diabetes mellitus	0.00277	0.0116	CbGpPWpGaD
Sibutramine—Dizziness—Ramipril—type 1 diabetes mellitus	0.00276	0.00362	CcSEcCtD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—type 1 diabetes mellitus	0.00275	0.0115	CbGpPWpGaD
Sibutramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—type 1 diabetes mellitus	0.00267	0.0112	CbGpPWpGaD
Sibutramine—Vomiting—Ramipril—type 1 diabetes mellitus	0.00265	0.00348	CcSEcCtD
Sibutramine—Rash—Ramipril—type 1 diabetes mellitus	0.00263	0.00345	CcSEcCtD
Sibutramine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00263	0.00345	CcSEcCtD
Sibutramine—Headache—Ramipril—type 1 diabetes mellitus	0.00261	0.00343	CcSEcCtD
Sibutramine—Nausea—Ramipril—type 1 diabetes mellitus	0.00248	0.00325	CcSEcCtD
Sibutramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—type 1 diabetes mellitus	0.00246	0.0103	CbGpPWpGaD
Sibutramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—type 1 diabetes mellitus	0.00244	0.0102	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CHRM2—type 1 diabetes mellitus	0.00233	0.00976	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—IL1B—type 1 diabetes mellitus	0.00228	0.00955	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—PRF1—type 1 diabetes mellitus	0.00212	0.00889	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—G6PC2—type 1 diabetes mellitus	0.00206	0.00866	CbGpPWpGaD
Sibutramine—SLC6A2—Monoamine Transport—IL1B—type 1 diabetes mellitus	0.00196	0.00822	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—G6PC2—type 1 diabetes mellitus	0.00183	0.00767	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—IL1B—type 1 diabetes mellitus	0.00173	0.00728	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00173	0.00726	CbGpPWpGaD
Sibutramine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—type 1 diabetes mellitus	0.00173	0.00725	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	0.00172	0.0072	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	0.00171	0.00717	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—TNF—type 1 diabetes mellitus	0.00165	0.00693	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00153	0.00643	CbGpPWpGaD
Sibutramine—SLC6A3—Dopaminergic Neurogenesis—STAT3—type 1 diabetes mellitus	0.00153	0.00643	CbGpPWpGaD
Sibutramine—SLC6A3—Parkinsons Disease Pathway—CASP3—type 1 diabetes mellitus	0.00151	0.00633	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—ABCC8—type 1 diabetes mellitus	0.0015	0.00629	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.0015	0.00628	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.00148	0.00622	CbGpPWpGaD
Sibutramine—SLC6A2—Monoamine Transport—TNF—type 1 diabetes mellitus	0.00142	0.00596	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC18A2—type 1 diabetes mellitus	0.00137	0.00575	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GAD2—type 1 diabetes mellitus	0.00131	0.00549	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—CP—type 1 diabetes mellitus	0.00126	0.00529	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—TNF—type 1 diabetes mellitus	0.00126	0.00528	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—type 1 diabetes mellitus	0.00125	0.00525	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.00122	0.00513	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC18A2—type 1 diabetes mellitus	0.00121	0.00509	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.00118	0.00497	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.00115	0.00481	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GAD1—type 1 diabetes mellitus	0.00114	0.00476	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—CP—type 1 diabetes mellitus	0.00112	0.00469	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—type 1 diabetes mellitus	0.00111	0.00465	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.00105	0.0044	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.000992	0.00416	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000929	0.0039	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000909	0.00382	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000806	0.00338	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000802	0.00337	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—CDK4—type 1 diabetes mellitus	0.000787	0.0033	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—NOS2—type 1 diabetes mellitus	0.000765	0.00321	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000696	0.00292	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000641	0.00269	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000641	0.00269	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.00064	0.00268	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000635	0.00267	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000617	0.00259	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000568	0.00238	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000563	0.00236	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000465	0.00195	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	0.00045	0.00189	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000414	0.00174	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	0.000399	0.00167	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000375	0.00158	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000307	0.00129	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000229	0.00096	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000203	0.00085	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	0.000142	0.000595	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	0.000133	0.000559	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	0.000116	0.000485	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	9.13e-05	0.000383	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	7.71e-05	0.000323	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	7.26e-05	0.000304	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	7.21e-05	0.000303	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	7.08e-05	0.000297	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	5.64e-05	0.000237	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	4.78e-05	0.0002	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	3.17e-05	0.000133	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	2.91e-05	0.000122	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	2.78e-05	0.000117	CbGpPWpGaD
